Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
2.670
-0.550 (-17.08%)
Aug 19, 2026, 4:00 PM EDT - Market closed

Intelligent Bio Solutions Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
4.224.223.053.111.26-
Revenue Growth
38.09%38.09%-1.90%147.58%--
Gross Profit
2.052.051.251.430.33-
Operating Income
-12.31-12.31-10.42-10.28-8.44-8.34
Net Income
-12.43-12.43-10.57-10.16-10.63-8.31
Earnings Per Share
-8.44-8.44-20.04-63.80--
EPS Growth
------

Revenue by Segment

Fiscal YearFY 2025FY 2024
Period EndingJun '25 Jun '24
United Kingdom
2.872.89
Asia Pacific (APAC)
0.030.04
Americas
0.020.01
Rest of World
0.130.16
Total
3.053.11

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
3.993.991.156.421.668.28
Total Debt
1.821.820.280.871.34-
Net Cash (Debt)
2.172.170.865.540.328.28
Net Cash Growth
194.42%151.58%-84.42%1633.80%-96.14%-34.11%
Net Cash Per Share
1.481.481.6434.81--

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-11.93-11.93-9.68-9.57-7.38-3.36
Capital Expenditures
-0.13-0.13-0.23-0.22-0.51-0.38
Free Cash Flow
-12.05-12.05-9.91-9.79-7.88-3.74
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
48.63%48.63%40.85%45.81%25.99%-
Operating Margin
-292.03%-292.03%-341.50%-330.46%-671.24%-
Pretax Margin
-295.80%-295.80%-347.41%-327.50%-848.50%-
Profit Margin
-294.91%-294.91%-346.23%-326.40%-845.89%-
FCF Margin
-285.94%-285.94%-324.62%-314.71%-627.15%-

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
1.521.303.891.925.15-